ALF-2111

N/A

Report date: 2025/01/26 17:55:20

Base Information

Drug NameALF-2111
Drug Alias NameAd5rHIPrNIS-131IAdenovirus-HIP-NISoncolytic adenovirus therapy expressing sodium iodide symporter (INSERM/Alfact Innovation)AdrHIP-NISALF-2111
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionSodium/iodide cotransporter stimulants
TargetsSodium/iodide cotransporter
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleAlfact Innovation
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A